This company is no longer in business. Investors can get details about any potential exits or failures here.

Lipidomics

Lipidomics

[Closed for Investment] Lipidomics, Inc. is here with the solution for inflammatory skin diseases. They develop cosmetics and pharmaceutical products for dry and sensitive skin that help replenish liquids that are deficient in the skin barrier. Lipidomics scientific founders have been studying fundamental skin biology and dermatology for over two decades, and their studies have led them to create a topical application of two specific lipids that are effective for treating dry skin that can often be a precursor to eczema. Current treatments can suppress the immune response or have detrimental effects on skin health. Lipidomics’ product helps prevent that, allowing the integrity of the skin barrier to remain intact without triggering an immune response.

Expand

Investment Overview

Raised this Round: Raised: $2,095

Deal Terms

Total Commitments ($USD)

Platform
Netcapital
Start Date
06/22/2018
Close Date
10/01/2018
Min. Goal
$10,000
Max. Goal
$106,999
Min. Investment

$101

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.94

Pre-Money Valuation

$2,801,443

Company & Team

Company

Year Founded
2016
Industry
Healthcare & Pharmaceuticals
Tech Sector
Location
Corvallis, Oregon
Company Website
Visit Website

Team

Employees
4

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
10/01/2018 Netcapital $2,801,443 $2,095 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Lipidomics on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $2,801,443
Price per Share: $1.94

Follow company

Follow Lipidomics on Netcapital

Buy Lipidomics's Deal Report

Warning: according to the close date for this deal, Lipidomics may no longer be accepting investments.

Lipidomics Deal Report

Get Kingscrowd's comprehensive report on Lipidomics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Lipidomics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Lipidomics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge